Trials / Unknown
UnknownNCT03791099
Porous Metronidazole Loaded Matrix for Local Treatment of Periodontitis.
Preparation and Analysis of Material, Biological and Clinical Parameters of Metronidazole-loaded Porous Matrices for Local Periodontitis Treatment
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Wroclaw Medical University · Academic / Other
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Aim of the study is the efficiency assessment of porous Metronidazole loaded matrix based on gelatin/hydroxyethylcellulose blend in treatment of deep periodontal pockets resulting from severe chronic periodontitis. The matrix was invented and produced in Department of Drug Form Technology, Wroclaw Medical University. The porous metronidazole (MTZ) loaded matrix was fabricated by the freeze-drying technique. The morphology, mechanical properties, in vitro degradation, MTZ release from dried sponge were evaluated and also the clinical trials were performed. Patients suffering from chronic periodontitis are examined. To evaluate oral hygiene API (Approximal Plaque Index) and the gum inflammation BOP (Bleeding on Probing) and PBI (Papilla Bleeding Index) indices are used. The clinical examination is performed 3 times. On the first visit the output indicators are defined. The subgingival scaling is performed and Metronidazol on porous matrix is applied to the selected periodontal pockets. 2 control tests of periodontal indices are carried out after one week and one month from the application. In the control group after scaling/root planing procedure, there is no application of metronidazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metronidazole | After subgingival ultrasonic scaling is performed, metronidazole in polymer matrix is applied to the selected periodontal pockets. |
Timeline
- Start date
- 2018-04-23
- Primary completion
- 2019-01-01
- Completion
- 2019-04-01
- First posted
- 2019-01-02
- Last updated
- 2019-01-04
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT03791099. Inclusion in this directory is not an endorsement.